| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
An analysis of alternative classification schemes for medical atlas mapping
|
Cromley, E.K.
|
|
1996
|
32 |
9 |
p. 1551-1559
9 p.
|
article
|
| 2 |
A phase II study of dacarbazine, cisplatin, interferon-α and high-dose interleukin-2 in ‘poor-risk’ metastatic melanoma
|
Proebstle, T.M.
|
|
1996
|
32 |
9 |
p. 1530-1533
4 p.
|
article
|
| 3 |
A realistic clinical perspective of tamoxifen and endometrial carcinogenesis
|
Assikis, V.J.
|
|
1996
|
32 |
9 |
p. 1464-1476
13 p.
|
article
|
| 4 |
Breast metastases of merkel cell carcinoma
|
Schnabel, T.
|
|
1996
|
32 |
9 |
p. 1617-1618
2 p.
|
article
|
| 5 |
Calendar of forthcoming meetings
|
|
|
1996
|
32 |
9 |
p. I-V
nvt p.
|
article
|
| 6 |
Communication skills: When, not if, to teach
|
Walker, L.G.
|
|
1996
|
32 |
9 |
p. 1457-1459
3 p.
|
article
|
| 7 |
Diagnostic and prognostic implications of genetic lesions in non-Hodgkin's lymphoma
|
Gaidano, G.
|
|
1996
|
32 |
9 |
p. 1477-1482
6 p.
|
article
|
| 8 |
Do we know what's best for prostate cancer?
|
Waxman, J.
|
|
1996
|
32 |
9 |
p. 1455-1456
2 p.
|
article
|
| 9 |
Editor's page announcing “Current Controversies in Cancer”
|
Senn, Hans-Jörg
|
|
1996
|
32 |
9 |
p. 1453-
1 p.
|
article
|
| 10 |
Effect of regional angiotensin ii infusion on the relationship between tumour blood flow and fluorouracil uptake in a liver metastasis animal model
|
Dworkin, M.J.
|
|
1996
|
32 |
9 |
p. 1580-1584
5 p.
|
article
|
| 11 |
Effects of interleukin-1α on ovarian carcinoma in patients with recurrent disease
|
Verschraegen, C.F.
|
|
1996
|
32 |
9 |
p. 1609-1611
3 p.
|
article
|
| 12 |
Expression of the 67 kD Laminin receptor in human ovarian carcinomas as defined by a monoclonal antibody, MLuC5
|
van den Brûle, F.A.
|
|
1996
|
32 |
9 |
p. 1598-1602
5 p.
|
article
|
| 13 |
Helping health professionals involved in cancer care acquire key interviewing skills—the impact of workshops
|
Maguire, P.
|
|
1996
|
32 |
9 |
p. 1486-1489
4 p.
|
article
|
| 14 |
Inhibition of Pgp activity and cell cycle-dependent chemosensitivity to doxorubicin in the multidrug-resistant LoVo human colon cancer cell line
|
Toffoli, G.
|
|
1996
|
32 |
9 |
p. 1591-1597
7 p.
|
article
|
| 15 |
International cancer news
|
|
|
1996
|
32 |
9 |
p. 1447-1452
6 p.
|
article
|
| 16 |
Is routine axillary nodal dissection necessary in the treatment of breast cancer?
|
Fentiman, I.S.
|
|
1996
|
32 |
9 |
p. 1460-1461
2 p.
|
article
|
| 17 |
Is routine axillary nodal dissection necessary in the treatment of breast cancer?
|
Epstein, R.
|
|
1996
|
32 |
9 |
p. 1461-1463
3 p.
|
article
|
| 18 |
Is routine axillary nodal dissection necessary in the treatment of breast cancer?
|
Barr, L.
|
|
1996
|
32 |
9 |
p. 1463-
1 p.
|
article
|
| 19 |
Letters to the editor: Comments on a case of radiation myelopathy after 2 × 8.5 Gy for inoperable non-small cell lung cancer, Dardoufas et al., European Journal of Cancer, 31A, Nos 13/14, pp. 2418–2419, 1995
|
Hocking, M.
|
|
1996
|
32 |
9 |
p. 1616-
1 p.
|
article
|
| 20 |
Letters to the editor: Comments on a case of radiation myelopathy after 2 × 8.5 Gy for inoperable non-small cell lung cancer, Dardoufas et al., European Journal of Cancer, 31A, Nos 13/14, pp. 2418–2419, 1995
|
Macbeth, F.
|
|
1996
|
32 |
9 |
p. 1616-1617
2 p.
|
article
|
| 21 |
Modulation of [5-125I]iododeoxyuridine incorporation into tumour and normal tissue DNA by methotrexate and thymidylate synthase inhibitors
|
Mester, J.
|
|
1996
|
32 |
9 |
p. 1603-1608
6 p.
|
article
|
| 22 |
Monitoring of asparaginase activity and asparagine levels in children on different asparaginase preparations
|
Boos, J.
|
|
1996
|
32 |
9 |
p. 1544-1550
7 p.
|
article
|
| 23 |
Multiple forms of TGF-β
1 in breast tissues: A biologically active form of the small latent complex of TGF-β
1
|
Baillie, R.
|
|
1996
|
32 |
9 |
p. 1566-1573
8 p.
|
article
|
| 24 |
Myocardial infarction associated with vinorelbine (NavelbineR)
|
Zabernigg, A.
|
|
1996
|
32 |
9 |
p. 1618-1619
2 p.
|
article
|
| 25 |
Pharmacological studies with cetrorelix (SB-75), a potent antagonist of luteinising hormone-releasing hormone
|
Reissmann, Th.
|
|
1996
|
32 |
9 |
p. 1574-1579
6 p.
|
article
|
| 26 |
Phase I pharmacokinetics and limited sampling strategies for the bioreductive alkylating drug EO9
|
McLeod, H.L.
|
|
1996
|
32 |
9 |
p. 1518-1522
5 p.
|
article
|
| 27 |
pS2 Protein expression in gastric carcinoma. An immunohistochemical and immunoradiometric study
|
Machado, J.-C.
|
|
1996
|
32 |
9 |
p. 1585-1590
6 p.
|
article
|
| 28 |
Screening for neuroblastoma: 20 years and still no answer
|
Craft, A.W.
|
|
1996
|
32 |
9 |
p. 1540-1543
4 p.
|
article
|
| 29 |
Standard versus alternating non-cross-resistant chemotherapy in extensive small cell lung cancer: An EORTC phase iii trial
|
Postmus, P.E.
|
|
1996
|
32 |
9 |
p. 1498-1503
6 p.
|
article
|
| 30 |
Suramin-induced neutropenia
|
Dawson, N.A.
|
|
1996
|
32 |
9 |
p. 1534-1539
6 p.
|
article
|
| 31 |
The basic fibroblast growth factor and its receptor in pulmonary adenocarcinomas: an investigation of their expression as prognostic markers
|
Takanami, I.
|
|
1996
|
32 |
9 |
p. 1504-1509
6 p.
|
article
|
| 32 |
The clinical significance of androgen receptors in breast cancer and their relation to histological and cell biological parameters
|
Kuenen-Boumeester, V.
|
|
1996
|
32 |
9 |
p. 1560-1565
6 p.
|
article
|
| 33 |
The Editorial office of the EJC has moved!
|
Senn, Hans-Jörg
|
|
1996
|
32 |
9 |
p. 1445-
1 p.
|
article
|
| 34 |
The impact of a psychological intervention on quality of life in non-metastatic breast cancer
|
Marchioro, G.
|
|
1996
|
32 |
9 |
p. 1612-1615
4 p.
|
article
|
| 35 |
Therapeutic equivalence of single oral doses of dolasetron mesilate and multiple doses of ondansetron for the prevention of emesis after moderately emetogenic chemotherapy
|
Fauser, A.A.
|
|
1996
|
32 |
9 |
p. 1523-1529
7 p.
|
article
|
| 36 |
The toxicity of radiotherapy following high-dose chemotherapy with peripheral blood stem cell support in high-risk breast cancer: a preliminary analysis
|
van der Wall, E.
|
|
1996
|
32 |
9 |
p. 1490-1497
8 p.
|
article
|
| 37 |
Third International Symposium on Hodgkin's Lymphoma in Köln, Germany
|
Engert, A.
|
|
1996
|
32 |
9 |
p. 1483-1485
3 p.
|
article
|
| 38 |
Treatment costs in hodgkin's disease: A cost-utility analysis
|
Norum, J.
|
|
1996
|
32 |
9 |
p. 1510-1517
8 p.
|
article
|
Journal description